Decline in forced vital capacity in subjects with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial compared with healthy reference subjects.
Respir Res
; 23(1): 178, 2022 Jul 05.
Article
in En
| MEDLINE
| ID: mdl-35790961
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Scleroderma, Systemic
/
Lung Diseases, Interstitial
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Respir Res
Year:
2022
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom